These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8306924)

  • 21. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium.
    Dorée JP; Des Rosiers J; Lew V; Gendron A; Elie R; Stip E; Tourjman SV
    Curr Med Res Opin; 2007 Feb; 23(2):333-41. PubMed ID: 17288688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium augmentation therapy in refractory depression-update 2002.
    Bauer M; Forsthoff A; Baethge C; Adli M; Berghöfer A; Döpfmer S; Bschor T
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):132-9. PubMed ID: 12904977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant combination and potentiation.
    Zajecka JM; Fawcett J
    Psychiatr Med; 1991; 9(1):55-75. PubMed ID: 2017568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term treatment of depressive illnesses].
    Deisenhammer EA; Hinterhuber H
    Wien Med Wochenschr; 1999; 149(18):515-9. PubMed ID: 10637956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating antidepressant nonresponders with augmentation strategies: an overview.
    Thase ME; Howland RH; Friedman ES
    J Clin Psychiatry; 1998; 59 Suppl 5():5-12; discussion 13-5. PubMed ID: 9635543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy resistance to antidepressive drugs: risk factors and treatment possibilities].
    Möller HJ
    Nervenarzt; 1991 Nov; 62(11):658-69. PubMed ID: 1770965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of thyroid supplements to augment antidepressant medication.
    Joffe RT
    J Clin Psychiatry; 1998; 59 Suppl 5():26-9; discussion 30-1. PubMed ID: 9635545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative approaches to refractory depression in bipolar illness.
    Post RM; Leverich GS; Denicoff KD; Frye MA; Kimbrell TA; Dunn R
    Depress Anxiety; 1997; 5(4):175-89. PubMed ID: 9338110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Survey and treatment strategy of antidepressant-resistant depression].
    Inoue T; Izumi T; Honma H; Ohmori T; Denda K; Kasahara T; Koyama T
    Seishin Shinkeigaku Zasshi; 1996; 98(5):329-42. PubMed ID: 8741286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium antidepressant augmentation in TCA-refractory depression in adolescents.
    Ryan ND; Meyer V; Dachille S; Mazzie D; Puig-Antich J
    J Am Acad Child Adolesc Psychiatry; 1988 May; 27(3):371-6. PubMed ID: 3379022
    [No Abstract]   [Full Text] [Related]  

  • 32. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium combinations in acute and maintenance treatment of unipolar and bipolar depression.
    Fawcett JA
    J Clin Psychiatry; 2003; 64 Suppl 5():32-7. PubMed ID: 12720482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic management of refractory depression.
    Patten SB; Lupin DA; Boucher SA; Lamarre CJ
    CMAJ; 1992 Feb; 146(4):483-7. PubMed ID: 1737312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Augmentation strategies for treatment-resistant depression: a literature review.
    Carvalho AF; Cavalcante JL; Castelo MS; Lima MC
    J Clin Pharm Ther; 2007 Oct; 32(5):415-28. PubMed ID: 17875106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of antidepressant-refractory depression: the relevance of unrecognized bipolarity.
    Inoue T; Nakagawa S; Kitaichi Y; Izumi T; Tanaka T; Masui T; Kusumi I; Denda K; Koyama T
    J Affect Disord; 2006 Oct; 95(1-3):61-7. PubMed ID: 16797078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium potentiation of tetracyclic antidepressants.
    Terao T; Yoshimura R; Abe K
    Biol Psychiatry; 1990 Dec; 28(12):1075-7. PubMed ID: 2289005
    [No Abstract]   [Full Text] [Related]  

  • 39. Triiodothyronine potentiation of the antidepressant effect of phenelzine.
    Joffe RT
    J Clin Psychiatry; 1988 Oct; 49(10):409-10. PubMed ID: 3170493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment of bipolar depression.
    Grof P
    Psychiatr J Univ Ott; 1989 Jun; 14(2):390-2; discussion 393. PubMed ID: 2503841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.